Data / Drug companies / Patheon Softgels Inc.
Patheon Softgels Inc.: 123 products in the FDA NDC directory, labeler code 10888
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Patheon Softgels Inc. (labeler code 10888) lists 123 products in the FDA National Drug Code Directory. By type: 122 drugs for further processing, 1 bulk ingredients. Its main marketing category is drugs for further processing. The newest product started marketing on October 15, 2025.
The request: Watch Patheon Softgels Inc. (FDA labeler code 10888): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 10888
- Products in commercial distribution
- 123
- Packages
- 123
- Finished drugs by generic name
- 0
- Prescription products
- 0
- Over the counter products
- 0
- Controlled substance products
- Schedule III 3
- Started marketing in the last 12 months
- 0
- Earliest marketing start
- October 16, 1978
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Drugs for further processing | 122 | 99.2% |
| Bulk ingredients for compounding | 1 | 0.8% |
Products by type
| Type | Products | Share |
|---|---|---|
| Drugs for further processing | 122 | 99.2% |
| Bulk ingredients | 1 | 0.8% |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Capsule | 59 | 48% |
| Capsule, liquid filled | 55 | 44.7% |
| Tablet, coated | 7 | 5.7% |
| Tablet | 1 | 0.8% |
| Capsule, gelatin coated | 1 | 0.8% |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Acetaminophen | 10888-8274 | Capsule, liquid filled | Drugs for further processing | October 15, 2025 |
| Ibuprofen | 10888-8277 | Capsule, liquid filled | Drugs for further processing | October 1, 2025 |
| Acetaminophen, guaifenesin, pseudoephedrine hcl, dextromethorphan hbr | 10888-8269 | Capsule, liquid filled | Drugs for further processing | July 21, 2025 |
| Acetaminophen, pseudoephedrine hcl, doxylamine succinate, dextromethorphan hbr | 10888-8268 | Capsule, liquid filled | Drugs for further processing | July 21, 2025 |
| Ibuprofen | 10888-8282 | Capsule, liquid filled | Drugs for further processing | July 17, 2025 |
| Acetaminophen | 10888-8249 | Capsule, liquid filled | Drugs for further processing | July 17, 2025 |
| Ibuprofen | 10888-8266 | Capsule | Drugs for further processing | May 28, 2025 |
| Progesterone | 10888-8145 | Capsule | Drugs for further processing | April 10, 2025 |
| Progesterone | 10888-8144 | Capsule | Drugs for further processing | April 10, 2025 |
| Simethicone | 10888-8267 | Capsule, liquid filled | Drugs for further processing | March 26, 2025 |
| Icosapent ethyl | 10888-8263 | Capsule, liquid filled | Drugs for further processing | April 24, 2024 |
| Ibuprofen | 10888-8272 | Capsule, liquid filled | Drugs for further processing | April 1, 2024 |
| Fexofenadine hydrochloride | 10888-8251 | Tablet, coated | Drugs for further processing | January 8, 2024 |
| Simethicone | 10888-8178 | Capsule, liquid filled | Drugs for further processing | November 29, 2023 |
| Icosapent ethyl | 10888-8220 | Capsule | Drugs for further processing | November 20, 2023 |
| Icosapent ethyl | 10888-8217 | Capsule | Drugs for further processing | November 20, 2023 |
| Naproxen sodium | 10888-8227 | Capsule, liquid filled | Drugs for further processing | October 16, 2023 |
| Acetaminophen, dextromethorphan hbr, doxylamine succinate capsule | 10888-8259 | Capsule, liquid filled | Drugs for further processing | June 29, 2023 |
| Acetaminophen, dextromethorphan hbr capsule | 10888-8258 | Capsule, liquid filled | Drugs for further processing | June 29, 2023 |
| Acetaminophen, dextromethorphan hbr, phenylephrine hcl capsule | 10888-8257 | Capsule, liquid filled | Drugs for further processing | June 29, 2023 |
| Naproxen sodium | 10888-8270 | Capsule, liquid filled | Drugs for further processing | June 27, 2023 |
| Naproxen sodium | 10888-8271 | Capsule, liquid filled | Drugs for further processing | June 20, 2023 |
| Icosapent ethyl | 10888-8219 | Capsule | Drugs for further processing | December 13, 2022 |
| Lubiprostone | 10888-5126 | Capsule | Drugs for further processing | December 13, 2022 |
| Lubiprostone | 10888-5124 | Capsule | Drugs for further processing | December 13, 2022 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.